GlassScriptPhysician profile
Gilah Freidel Weissman
NPI 1265638688
$1,802.26
in general payments reported to CMS, 2019-2025
14 companies · $1,329 in 2025
The $1,329 reported for 2025 was more than what 86% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.91 · 2022: $26.69 · 2023: $137 · 2024: $263 · 2025: $1,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081 · Travel and Lodging: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,081.07 |
| Travel and Lodging | $647.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,098.02 | 2023-2025 | Spravato |
| Vanda Pharmaceuticals INC. | $110.31 | 2025 | Fanapt, Hetlioz |
| Teva Pharmaceuticals USA, INC. | $108.61 | 2022-2023 | Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $103.16 | 2024-2025 | Rexulti |
| Corium, LLC | $82.77 | 2024-2025 | Azstarys |
| Axsome Therapeutics, INC. | $72.06 | 2025 | Auvelity |
| Abbvie INC. | $51.56 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.91 | 2021 | |
| Supernus Pharmaceuticals, INC. | $35.16 | 2024 | Qelbree |
| Collegium Pharmaceutical, INC. | $31.77 | 2025 | Jornay Pm |
| Biogen, INC. | $19.00 | 2025 | Zurzuvae |
| Noven Therapeutics, LLC | $16.48 | 2025 | Xelstrym |
| Vertical Pharmaceuticals, LLC | $14.73 | 2025 | Relexxii |
| Lilly USA, LLC | $11.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilah Weissman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.